Spring/Summer 2026
Partner update: School of Nursing

Betty Irene Moore School of Nursing Alumni Updates

  • A group shot of school of nursing alumni during a reunion/picnic

    Alumni gather at reunion/picnic

    On Sat., March 14, 30 alumni, their families, and School of Nursing faculty and staff gathered on Vanderhoef Commons and in Betty Irene Moore Hall to celebrate their time at the Betty Irene Moore School of Nursing at UC Davis. Graduates from all programs — including the PA and NP certificate programs — enjoyed a laid-back, family-friendly atmosphere with lawn games, a photo booth and treats like Rich’s ice cream cart and Pi Day pies. Alumni from as early as the class of 1973 joined recent graduates, making it a true cross-generational reunion.

  • A top 10 Outstanding Global Filipino Nurse

    Assistant Professor Zyrene Marsh, D.N.P., A.P.R.N., F.N.P.-C., was named one of the 10 Outstanding Global Filipino Nurses by the Philippines Nurses Association of America (PNAA). The award celebrates significant contributions in international practice, research, education and policy advocacy.

  • Professor to lead statewide advisory board

    Professor Leigh Ann Simmons, Ph.D., M.F.T., F.A.A.H.B., has been appointed to and named vice chair of the advisory board for the California Initiative to Advance Precision Medicine. Launched in 2015, the initiative drives development of innovative technologies and personalized strategies to coordinate cross-sector partnerships for prevention, diagnosis and treatment. The council advises the California Health and Human Services Agency (CalHHS).

  • Professor co-authors policy statement for American Heart Association

    Professor Shu-Fen Wung, Ph.D., R.N., A.C.N.P., F.A.A.N., co-authored the policy statement, “Genetic and Genomic Testing in Cardiovascular Disease,” in Circulation. It updates a previous AHA policy from over a decade ago and provides a comprehensive framework for public policy, serving as a roadmap for policymakers, payers and researchers. The goal is ensuring equitable access, appropriate regulatory oversight, and ethical stewardship of data related to genetic and genomic testing.